ABSTRACT
A common perspective in post-stroke gait training is that walking at the fastest safe speed maximizes the quality of gait biomechanics, but effects on compensatory biomechanics and inter-limb asymmetry have not been widely characterized. It is unclear whether walking at the fastest speed maximizes the quality of (i.e., optimizes) post-stroke biomechanics across variables, individuals, and walking function levels. In low- (n=9) and high-functioning (n=9) stroke survivors walking at six individualized speeds, we determined if walking at the fastest speed optimized 16 biomechanical variables. Across participants, 46% of magnitude and 17% of asymmetry variables were optimized at the fastest speed, but the optimized variables differed across individuals. Some inter-limb asymmetry variables sustained large biomechanical costs, (i.e., biomechanical quality lost by walking at the fastest vs. the optimal speed; difference in Cohen’s d=0.1-0.7). In both groups, faster speeds were associated with increased (improved) paretic-leg trailing limb angle, peak ankle moment, and peak hip and ankle power magnitudes (all p<0.001), but changes in inter-limb asymmetry were individual-specific. Our findings suggest that treadmill training at the fastest safe speed does not maximize gait quality across individuals or biomechanical variables. More holistic, individual-specific gait quality metrics are needed to guide gait speed optimization during rehabilitation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03466372
Funding Statement
Research reported in this manuscript was supported by the National Institute of Child Health and Human Development under award number F32HD108927 to MR, and R01HD095975 and K01HD079584 to TK. This work was also supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1937971 to TW. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of Emory University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Updated results with 4 additional participants
LIST OF ABBREVIATIONS
- AGRF
- Anterior ground reaction force
- IC
- Initial contact
- Fast
- Fastest safe speed
- Opt
- Optimal speed
- SS
- Self-selected speed
- TLA
- Trailing limb angle
